Skip to main content
Erschienen in: Cancer Causes & Control 1/2009

01.02.2009 | Original Paper

Risk factors for thyroid cancer: an epidemiological review focused on nutritional factors

verfasst von: Luigino Dal Maso, Cristina Bosetti, Carlo La Vecchia, Silvia Franceschi

Erschienen in: Cancer Causes & Control | Ausgabe 1/2009

Einloggen, um Zugang zu erhalten

Abstract

Objectives

The present review summarizes epidemiological evidence on risk factors for thyroid cancer (TC), in particular, nutritional factors.

Methods

Searches of articles on the issue were conducted using MEDLINE.

Results

Exposure to ionizing radiation, particularly during childhood, is the best-established risk factor for TC. There is also a strong association with history of benign nodules/adenoma or goiter. Iodine deficiency may induce an increasing incidence of benign thyroid conditions, but very high iodine intake also affects thyroid function and, possibly, TC risk. Among dietary factors, fish—the major natural source of iodine in human diet—is not consistently related to TC risk. High intake of cruciferous vegetables shows a weak inverse association with TC. Among other food groups, vegetables other than cruciferous are the only food group showing a favorable effect on TC, with an approximate 20% reduction in risk for subjects with the highest consumption. No effect on TC risk of alcohol, coffee, or other food-groups/nutrients emerged. Height and weight at diagnosis show a moderate positive association with TC risk.

Conclusion

At present, the only recognized measures for reducing TC risk is to avoid ionizing radiation and iodine deficiency, particularly in childhood and young women, and to increase vegetable consumption.
Literatur
1.
Zurück zum Zitat Ferlay J, Bray F, Pisani P, Parkin DM (2004) GLOBOCAN 2002. Cancer incidence, mortality and prevalence worldwide. IARC CancerBase No.5, version 2.0. IARC Press, Lyon, France Ferlay J, Bray F, Pisani P, Parkin DM (2004) GLOBOCAN 2002. Cancer incidence, mortality and prevalence worldwide. IARC CancerBase No.5, version 2.0. IARC Press, Lyon, France
3.
4.
Zurück zum Zitat De Lellis RA, Lloyd RV, Heitz PU, Eng C (2004) World Health Organization Classification of tumours. Pathology and genetics of tumours of endocrine organs. IARC Press, Lyon, France De Lellis RA, Lloyd RV, Heitz PU, Eng C (2004) World Health Organization Classification of tumours. Pathology and genetics of tumours of endocrine organs. IARC Press, Lyon, France
5.
Zurück zum Zitat Curado MP, Edwards B, Shin HR et al (eds) (2007) Cancer incidence in five continents, vol IX. IARC Sci Publ No. 160. IARC, Lyon Curado MP, Edwards B, Shin HR et al (eds) (2007) Cancer incidence in five continents, vol IX. IARC Sci Publ No. 160. IARC, Lyon
7.
14.
Zurück zum Zitat Horn-Ross PL, Morris SJ, Lee MM et al (2001) Iodine and thyroid cancer risk among women in a multiethnic population: the Bay Area Thyroid Cancer Study. Cancer Epidemiol Biomarkers Prev 10:979–985PubMed Horn-Ross PL, Morris SJ, Lee MM et al (2001) Iodine and thyroid cancer risk among women in a multiethnic population: the Bay Area Thyroid Cancer Study. Cancer Epidemiol Biomarkers Prev 10:979–985PubMed
15.
Zurück zum Zitat Memon A, Darif M, Al-Saleh K, Suresh A (2002) Epidemiology of reproductive and hormonal factors in thyroid cancer: evidence from a case–control study in the Middle East. Int J Cancer 97:82–89. doi:10.1002/ijc.1573 PubMedCrossRef Memon A, Darif M, Al-Saleh K, Suresh A (2002) Epidemiology of reproductive and hormonal factors in thyroid cancer: evidence from a case–control study in the Middle East. Int J Cancer 97:82–89. doi:10.​1002/​ijc.​1573 PubMedCrossRef
16.
Zurück zum Zitat Zivaljevic V, Vlajinac H, Jankovic R, Marinkovic J, Diklic A, Paunovic I (2006) Case–control study of anaplastic thyroid cancer. Tumori 90:9–12. doi:10.1159/000091608 CrossRef Zivaljevic V, Vlajinac H, Jankovic R, Marinkovic J, Diklic A, Paunovic I (2006) Case–control study of anaplastic thyroid cancer. Tumori 90:9–12. doi:10.​1159/​000091608 CrossRef
17.
Zurück zum Zitat Troung T, Orsi L, Dubourdieu D, Rougier Y, Hémon D, Guénel P (2005) Role of goiter and of menstrual and reproductive factors in thyroid cancer: a population-based case–control study in New Caledonia (South Pacific), a very high incidence area. Am J Epidemiol 161:1056–1065. doi:10.1093/aje/kwi136 CrossRef Troung T, Orsi L, Dubourdieu D, Rougier Y, Hémon D, Guénel P (2005) Role of goiter and of menstrual and reproductive factors in thyroid cancer: a population-based case–control study in New Caledonia (South Pacific), a very high incidence area. Am J Epidemiol 161:1056–1065. doi:10.​1093/​aje/​kwi136 CrossRef
18.
Zurück zum Zitat Wong EY, Ray R, Gao DL et al (2006) Reproductive history, occupational exposures, and thyroid cancer risk among women textile workers in Shanghai, China. Int Arch Environ Health 79:251–258. doi:10.1007/s00420-005-0036-9 CrossRef Wong EY, Ray R, Gao DL et al (2006) Reproductive history, occupational exposures, and thyroid cancer risk among women textile workers in Shanghai, China. Int Arch Environ Health 79:251–258. doi:10.​1007/​s00420-005-0036-9 CrossRef
22.
Zurück zum Zitat IARC Working Group on the Evaluation of Cancer-preventive Agents (1998) IARC handbooks of cancer prevention. Vitamin A. IARC WHO, Lyon, France IARC Working Group on the Evaluation of Cancer-preventive Agents (1998) IARC handbooks of cancer prevention. Vitamin A. IARC WHO, Lyon, France
23.
Zurück zum Zitat IARC Working Group on the Evaluation of Cancer-preventive Agents (1998) IARC handbooks of cancer prevention. Carotenoids. IARC WHO, Lyon, France IARC Working Group on the Evaluation of Cancer-preventive Agents (1998) IARC handbooks of cancer prevention. Carotenoids. IARC WHO, Lyon, France
24.
Zurück zum Zitat IARC Working Group on the Evaluation of Cancer-preventive Strategies (2003) IARC handbooks of cancer prevention. Fruit and vegetables. IARC Press, Lyon, France IARC Working Group on the Evaluation of Cancer-preventive Strategies (2003) IARC handbooks of cancer prevention. Fruit and vegetables. IARC Press, Lyon, France
25.
Zurück zum Zitat Franceschi S, Dal Maso L (1999) Hormonal imbalances and thyroid cancers in humans. In: Capen CC, Dybing E, Rice JM, Wilbourn JD (eds) Species differences in thyroid, kidney and urinary bladder carcinogenesis. IARC, Lyon, France, pp 33–43 Franceschi S, Dal Maso L (1999) Hormonal imbalances and thyroid cancers in humans. In: Capen CC, Dybing E, Rice JM, Wilbourn JD (eds) Species differences in thyroid, kidney and urinary bladder carcinogenesis. IARC, Lyon, France, pp 33–43
26.
Zurück zum Zitat Kane AB, Boffetta P, Saracci R, Wilbourn JD (1996) Mechanisms of fibre carcinogenesis. IARC, Lyon, France Kane AB, Boffetta P, Saracci R, Wilbourn JD (1996) Mechanisms of fibre carcinogenesis. IARC, Lyon, France
27.
Zurück zum Zitat Ron E (1996) Epidemiology of thyroid cancer. In: Schottenfeld S, Fraumeni JR Jr (eds) Cancer epidemiology and prevention. Oxford University Press, Oxford, pp 1000–1021 Ron E (1996) Epidemiology of thyroid cancer. In: Schottenfeld S, Fraumeni JR Jr (eds) Cancer epidemiology and prevention. Oxford University Press, Oxford, pp 1000–1021
28.
Zurück zum Zitat IARC Working Group on the Evaluation of Cancer-preventive Strategies (2002) IARC handbooks of cancer prevention. Weight control and physical activity. IARC Press, Lyon, France IARC Working Group on the Evaluation of Cancer-preventive Strategies (2002) IARC handbooks of cancer prevention. Weight control and physical activity. IARC Press, Lyon, France
29.
Zurück zum Zitat de Benoist B, Andersson M, Egli I, Takkouche B, Allen H (2004) Iodine status worldwide. WHO global database on iodine deficiency. World Health Organization, Geneva de Benoist B, Andersson M, Egli I, Takkouche B, Allen H (2004) Iodine status worldwide. WHO global database on iodine deficiency. World Health Organization, Geneva
30.
Zurück zum Zitat Willett WC (1998) Nutritional epidemiology. In: Rothman KJ, Greenland S (eds) Modern epidemiology, 2nd edn. Lippincott-Raven Publishers, Philadelphia, pp 623–642 Willett WC (1998) Nutritional epidemiology. In: Rothman KJ, Greenland S (eds) Modern epidemiology, 2nd edn. Lippincott-Raven Publishers, Philadelphia, pp 623–642
31.
33.
Zurück zum Zitat Cardis E, Kesminiene A, Ivanov V et al (2005) Risk of thyroid cancer after exposure to 131I in childhood. J Natl Cancer Inst 97:724–732PubMedCrossRef Cardis E, Kesminiene A, Ivanov V et al (2005) Risk of thyroid cancer after exposure to 131I in childhood. J Natl Cancer Inst 97:724–732PubMedCrossRef
34.
Zurück zum Zitat Liska J, Altanerova V, Galbavy S, Stvrtina S, Brtko J (2005) Thyroid tumors: histological classification and genetic factors involved in the development of thyroid cancer. Endocr Regul 39:73–83PubMed Liska J, Altanerova V, Galbavy S, Stvrtina S, Brtko J (2005) Thyroid tumors: histological classification and genetic factors involved in the development of thyroid cancer. Endocr Regul 39:73–83PubMed
42.
Zurück zum Zitat Rasmussen LB, Ovesen L, Bülow I et al (2002) Relations between various measures of iodine intake and thyroid volume, thyroid nodularity, and serum thyroglobulin1−3. Am J Clin Nutr 76:1069–1076PubMed Rasmussen LB, Ovesen L, Bülow I et al (2002) Relations between various measures of iodine intake and thyroid volume, thyroid nodularity, and serum thyroglobulin1−3. Am J Clin Nutr 76:1069–1076PubMed
44.
45.
Zurück zum Zitat Williams ED, Doniach I, Bjarnason O, Michie W (1977) Thyroid cancer in iodide rich area: a histopathological study. Cancer 39:215–222. doi :10.1002/1097-0142(197701)39:1<215::AID-CNCR2820390134>3.0.CO;2-#PubMedCrossRef Williams ED, Doniach I, Bjarnason O, Michie W (1977) Thyroid cancer in iodide rich area: a histopathological study. Cancer 39:215–222. doi :10.1002/1097-0142(197701)39:1<215::AID-CNCR2820390134>3.0.CO;2-#PubMedCrossRef
47.
Zurück zum Zitat La Vecchia C, Ron E, Franceschi S et al (1999) A pooled analysis of case–control studies of thyroid cancer. III. Oral contraceptives, menopausal replacement therapy and other female hormones. Cancer Causes Control 10:157–166. doi:10.1023/A:1008832513932 PubMedCrossRef La Vecchia C, Ron E, Franceschi S et al (1999) A pooled analysis of case–control studies of thyroid cancer. III. Oral contraceptives, menopausal replacement therapy and other female hormones. Cancer Causes Control 10:157–166. doi:10.​1023/​A:​1008832513932 PubMedCrossRef
48.
49.
Zurück zum Zitat Sakoda LC, Horn-Ross PL (2002) Reproductive and menstrual history and papillary thyroid cancer risk: the San Francisco Bay Area Thyroid Cancer Study. Cancer Epidemiol Biomarkers Prev 11:51–57PubMed Sakoda LC, Horn-Ross PL (2002) Reproductive and menstrual history and papillary thyroid cancer risk: the San Francisco Bay Area Thyroid Cancer Study. Cancer Epidemiol Biomarkers Prev 11:51–57PubMed
52.
Zurück zum Zitat Lind P, Langsteger W, Molnar M, Gallowitsch HJ, Mikosch P, Gomez I (1998) Epidemiology of thyroid diseases in iodine sufficiency. Thyroid 8:1179–1183PubMed Lind P, Langsteger W, Molnar M, Gallowitsch HJ, Mikosch P, Gomez I (1998) Epidemiology of thyroid diseases in iodine sufficiency. Thyroid 8:1179–1183PubMed
53.
Zurück zum Zitat Franceschi S (1998) Iodine intake and thyroid carcinoma—a potential risk factor. Exp Clin Endocrinol Diab 106(Suppl 3):S38–S44 Franceschi S (1998) Iodine intake and thyroid carcinoma—a potential risk factor. Exp Clin Endocrinol Diab 106(Suppl 3):S38–S44
55.
Zurück zum Zitat Weissel M (2003) Legal augmentation of iodine content in table salt from 10 to 20 mg Kl/kg: documented effects a decade later. Exp Clin Endocrinol Diab 111:187–190. doi:10.1055/s-2003-40461 CrossRef Weissel M (2003) Legal augmentation of iodine content in table salt from 10 to 20 mg Kl/kg: documented effects a decade later. Exp Clin Endocrinol Diab 111:187–190. doi:10.​1055/​s-2003-40461 CrossRef
57.
Zurück zum Zitat Glattre E, Haldorsen T, Berg JP, Stensvold I, Solvoll K (1993) Norwegian case–control study testing the hypothesis that seafood increases the risk of thyroid cancer. Cancer Causes Control 4:11–16. doi:10.1007/BF00051708 PubMedCrossRef Glattre E, Haldorsen T, Berg JP, Stensvold I, Solvoll K (1993) Norwegian case–control study testing the hypothesis that seafood increases the risk of thyroid cancer. Cancer Causes Control 4:11–16. doi:10.​1007/​BF00051708 PubMedCrossRef
59.
Zurück zum Zitat Kanno J, Matsouoka C, Furuta K et al (1999) Tumor promoting effect of goitrogens on the rat thyroid. Toxicol Pathol 18:239–246 Kanno J, Matsouoka C, Furuta K et al (1999) Tumor promoting effect of goitrogens on the rat thyroid. Toxicol Pathol 18:239–246
60.
61.
Zurück zum Zitat Yin F, Giuliano AE, Van Herle AJ (1999) Growth inhibitory effects of flavonoids in human thyroid cancer cell lines. Thyroid 9:369–376PubMedCrossRef Yin F, Giuliano AE, Van Herle AJ (1999) Growth inhibitory effects of flavonoids in human thyroid cancer cell lines. Thyroid 9:369–376PubMedCrossRef
63.
Zurück zum Zitat Horn-Ross PL, Hoggatt KJ, Lee MM (2002) Phytoestrogens and thyroid cancer risk: the San Francisco Bay Area Thyroid Cancer Study. Cancer Epidemiol Biomarkers Prev 11:43–49PubMed Horn-Ross PL, Hoggatt KJ, Lee MM (2002) Phytoestrogens and thyroid cancer risk: the San Francisco Bay Area Thyroid Cancer Study. Cancer Epidemiol Biomarkers Prev 11:43–49PubMed
64.
Zurück zum Zitat Berg JP, Glattre E, Haldorsen T et al (1994) Longchain serum fatty acids and risk of thyroid cancer: a population-based case–control study in Norway. Cancer Causes Control 5:433–439. doi:10.1007/BF01694757 PubMedCrossRef Berg JP, Glattre E, Haldorsen T et al (1994) Longchain serum fatty acids and risk of thyroid cancer: a population-based case–control study in Norway. Cancer Causes Control 5:433–439. doi:10.​1007/​BF01694757 PubMedCrossRef
66.
Zurück zum Zitat Galanti MR, Hansson L, Bergstrom R et al (1997) Diet and the risk of papillary and follicular thyroid carcinoma: a population-based case–control study in Sweden and Norway. Cancer Causes Control 8:205–214. doi:10.1023/A:1018424430711 PubMedCrossRef Galanti MR, Hansson L, Bergstrom R et al (1997) Diet and the risk of papillary and follicular thyroid carcinoma: a population-based case–control study in Sweden and Norway. Cancer Causes Control 8:205–214. doi:10.​1023/​A:​1018424430711 PubMedCrossRef
68.
Zurück zum Zitat Mack WJ, Preston-Martin S, Dal Maso L et al (2003) A pooled analysis of case–control studies of thyroid cancer: cigarette smoking and consumption of alcohol, coffee, and tea. Cancer Causes Control 14:773–785. doi:10.1023/A:1026349702909 PubMedCrossRef Mack WJ, Preston-Martin S, Dal Maso L et al (2003) A pooled analysis of case–control studies of thyroid cancer: cigarette smoking and consumption of alcohol, coffee, and tea. Cancer Causes Control 14:773–785. doi:10.​1023/​A:​1026349702909 PubMedCrossRef
69.
70.
Zurück zum Zitat D’Avanzo B, Ron E, La Vecchia C, Franceschi S, Negri E, Ziegler R (1997) Selected micronutrient intake and thyroid carcinoma risk. Cancer 79:2186–2192. doi :10.1002/(SICI)1097-0142(19970601)79:11<2186::AID-CNCR17>3.0.CO;2-SPubMedCrossRef D’Avanzo B, Ron E, La Vecchia C, Franceschi S, Negri E, Ziegler R (1997) Selected micronutrient intake and thyroid carcinoma risk. Cancer 79:2186–2192. doi :10.1002/(SICI)1097-0142(19970601)79:11<2186::AID-CNCR17>3.0.CO;2-SPubMedCrossRef
72.
Zurück zum Zitat Haselkorn T, Stewart SL, Horn-Ross PL (2003) Why are thyroid cancer rates so high in Southeast Asian women living in the United States? The Bay area Thyroid cancer study. Cancer Epidemiol Biomarkers Prev 12:1444–1450 Haselkorn T, Stewart SL, Horn-Ross PL (2003) Why are thyroid cancer rates so high in Southeast Asian women living in the United States? The Bay area Thyroid cancer study. Cancer Epidemiol Biomarkers Prev 12:1444–1450
73.
Zurück zum Zitat Ron E, Kleinerman RA, Boice JD Jr, LiVolsi VA, Flannery JT, Fraumeni JR Jr (1987) A population-based case–control study of thyroid cancer. J Natl Cancer Inst 79:1–12PubMed Ron E, Kleinerman RA, Boice JD Jr, LiVolsi VA, Flannery JT, Fraumeni JR Jr (1987) A population-based case–control study of thyroid cancer. J Natl Cancer Inst 79:1–12PubMed
77.
Zurück zum Zitat Vella V, Sciacca L, Pandini G et al (2001) The IGF system in thyroid cancer: new concepts. J Clin Pathol Mol Pathol 54:121–125 Vella V, Sciacca L, Pandini G et al (2001) The IGF system in thyroid cancer: new concepts. J Clin Pathol Mol Pathol 54:121–125
79.
Zurück zum Zitat Wingren G, Hatschek T, Axelson O (1993) Determinants of papillary cancer of the thyroid. Am J Epidemiol 138:482–491PubMed Wingren G, Hatschek T, Axelson O (1993) Determinants of papillary cancer of the thyroid. Am J Epidemiol 138:482–491PubMed
81.
Zurück zum Zitat World Cancer Research Fund, American Institute for Cancer Research (2007) Food nutrition, physical activity and the prevention of cancer: a global perspective. American Institute for Cancer Research, Washington, DC World Cancer Research Fund, American Institute for Cancer Research (2007) Food nutrition, physical activity and the prevention of cancer: a global perspective. American Institute for Cancer Research, Washington, DC
82.
Zurück zum Zitat Willett WC (2006) Diet and nutrition. In: Schottenfeld S, Fraumeni JR Jr (eds) Cancer epidemiology and prevention, 3rd edn. Oxford University Press, Oxford, pp 405–421 Willett WC (2006) Diet and nutrition. In: Schottenfeld S, Fraumeni JR Jr (eds) Cancer epidemiology and prevention, 3rd edn. Oxford University Press, Oxford, pp 405–421
Metadaten
Titel
Risk factors for thyroid cancer: an epidemiological review focused on nutritional factors
verfasst von
Luigino Dal Maso
Cristina Bosetti
Carlo La Vecchia
Silvia Franceschi
Publikationsdatum
01.02.2009
Verlag
Springer Netherlands
Erschienen in
Cancer Causes & Control / Ausgabe 1/2009
Print ISSN: 0957-5243
Elektronische ISSN: 1573-7225
DOI
https://doi.org/10.1007/s10552-008-9219-5

Weitere Artikel der Ausgabe 1/2009

Cancer Causes & Control 1/2009 Zur Ausgabe

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.